Výsledky vyhledávání - "Camilla Albina Zanco Fogassa"

Immunotherapy as Single Treatment for Patients With NSCLC With Brain Metastases: A Systematic Review and Meta-Analysis—the META-L-BRAIN Study

Autor: Marcos Pedro Guedes Camandaroba, Viviane Teixeira Loiola de Alencar, Vladmir Cláudio Cordeiro de Lima, Rafaela Pirolli, Camilla Albina Zanco Fogassa

Publikováno v: Journal of Thoracic Oncology. 16:1379-1391

Introduction Brain metastases (BMs) occur in 40% of patients with lung cancer. The activity of immunotherapy in these patients, however, remains controversial, as the cornerstone treatment is radiotherapy (RT). Because RT is associated with adverse e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::310858df23e791e16a1faa58376b9c8b
https://doi.org/10.1016/j.jtho.2021.04.014

Zobrazit plný text záznamu

Abstract P2-16-30: Neoadjuvant therapy outcomes in non metastatic invasive breast carcinomas - Results from a large Brazilian cohort

Autor: Vladmir C. Cordeiro Lima, Marina de Paula Canal, Cynthia A Bueno, Marina Sonagli, Poliana de Andrade, Fernanda A Oliveira, Fabiana Baroni Alves Makdissi, Mariana P Xerfan, Sinara Figueiredo, Fernando Ab Campos, Solange Moraes Sanches, Monique Celeste Tavares, Rafaela Pirolli, Bruna Raphaeli Silva Mattos, Vinicius Fernando Calsavara, Marcelle Goldner Cesca, Camilla Albina Zanco Fogassa

Publikováno v: Cancer Research. 80:P2-16

Introduction: Neoadjuvant chemotherapy in addition to increasing the rate of breast conservation, offers a invaluable opportunity to monitor individual tumor response which may be related to survival outcomes. In view of this, neoadjuvant treatment h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bd30cfbebea2fccc150bf728c509ddd0
https://doi.org/10.1158/1538-7445.sabcs19-p2-16-30

Zobrazit plný text záznamu

HER2-Low Status and Response to Neoadjuvant Chemotherapy in HER2 Negative Early Breast Cancer

Autor: Rafael Lima Viana, M.F. Simões, Fernando Augusto Batista Campos, Vladmir Cláudio Cordeiro de Lima, Luciana de Moura Leite, Bruna Raphaeli Silva Mattos, Paula Tavares Guimarães, Noam Pondé, Debora Maciel Santana, Daniella Dias Silva Sá, F. Rocha, Sinara Figueiredo Silva, Erick Figueiredo Saldanha, Solange Moraes Sanches, Marcelle Goldner Cesca, Rafaela Pirolli, Camilla Albina Zanco Fogassa, Monique Celeste Tavares, Simone Klog Loose

Purpose: Recently, phase I studies with novel antibody drug conjugates targeting HER2 suggested benefit in HER2-low patients – defined as immunohistochemistry(IHC) +1 or +2 FISH/ISH non-amplified, with advanced breast cancer(BC). Data on the progno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98fd26dd52572004e785fb728f0e6d0
https://doi.org/10.21203/rs.3.rs-420934/v1

Zobrazit plný text záznamu

176P Pathological complete response to neoadjuvant systemic therapy in 1160 initial and locally advanced breast cancer patients: Real life data on outcomes

Publikováno v: Annals of Oncology. 32:S435-S436

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa6eacaad4dfb9bc8079299e77d3d317
https://doi.org/10.1016/j.annonc.2021.08.457

Zobrazit plný text záznamu

Evaluation of prognostic factors in patients undergoing first-line chemotherapy for advanced biliary tract cancer: a retrospective analysis from a South American cancer centre

Autor: Tiago Cordeiro Felismino, Felipe Marcio Araujo Oliveira, Camilla Albina Zanco Fogassa, Silvia Nardozza Santerini, Victor Hugo Fonseca de Jesus, Rachel Simões Pimenta Riechelmann, Felipe José Fernandez Coimbra, Celso Abdon Lopes Mello

Publikováno v: Ecancermedicalscience. 16

Biliary tract cancers (BTCs) are rare tumours with regional differences. Prognostic factors are poorly understood. Gemcitabine + platinum (GP) is the standard first-line chemotherapy in metastatic patients. We aimed to search for prognostic factors i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f507bd0b3f03d74cc1c6d47f1dbc89b
https://pubmed.ncbi.nlm.nih.gov/35242226

Zobrazit plný text záznamu

256P Risk of CNS metastasis after neoadjuvant chemotherapy: Pathological complete response may not be enough

Autor: Poliana de Andrade, Marcelle Goldner Cesca, Monique Celeste Tavares, Solange Moraes Sanches, Flores Campos, V.C.C. de Lima, Camilla Albina Zanco Fogassa, Rafaela Pirolli, Simone Klog Loose, Luciana de Moura Leite, F.A. de Oliveira, Bruna Raphaeli Silva Mattos, Sinara Figueiredo Silva

Publikováno v: Annals of Oncology. 31:S342

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a2302148f92186e9f92a3eb95623188b
https://doi.org/10.1016/j.annonc.2020.08.065

Zobrazit plný text záznamu

Discordance between molecular subtyping from pre- and post-neoadjuvant chemotherapy (NACT) biopsy specimens in a Brazilian breast cancer cohort

Autor: Marcelle Goldner Cesca, Vladmir Cláudio Cordeiro de Lima, Solange Moraes Sanches, Fernanda A. Oliveira, Sinara Figueiredo Silva, Fernando Augusto Batista Campos, Rafaela Pirolli, Monique Celeste Tavares, Camilla Albina Zanco Fogassa, Poliana de Andrade, Mariana Pinheiro Xerfan, Luciana de Moura Leite, Bruna Raphaeli Silva Mattos

Publikováno v: Web of Science

e12649 Background: Discordance between immunohistochemistry (IHC) and molecular subtyping from pre and post neoadjuvant chemotherapy (NACT) biopsy specimens in breast cancer (BC) patients (pts) varies in the literature. This information could have pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::867d001c75796988ae2fb086a915754b
https://doi.org/10.1200/jco.2020.38.15_suppl.e12649

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání